Fiji vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Fiji rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Kazakhstan
How they compare
Fiji currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 7 times across 18 shared years of data; in 2006 it was Fiji ahead.
Fiji ranks 1st and Kazakhstan ranks 1st of 180 countries.
Across the 3 decades both report, Fiji averaged higher in 1 and Kazakhstan in 2.
Head to head by decade
| Decade | Fiji | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.7% | 51.0% | 15.7% | Fiji |
| 2010s | 48.1% | 87.4% | 39.3% | Kazakhstan |
| 2020s | 81.8% | 100.0% | 18.2% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Kazakhstan?
- Fiji, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Kazakhstan?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Kazakhstan?
- 18 years are reported by both, from 2006 to 2024.
- How do Fiji and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.